To evaluate the effects of intravitreal autologous plasmin injection (IVAP) on vitreoretinal diseases and vitreolysis.
Methods
In this interventional, prospective, case series pilot study, 8 eyes were assigned to IVAP. Plasminogen as centrifuged from the patients’ plasma was converted to plasmin by adding urokinase. A total of 0.2 mL extracted plasmin was injected intravitreally. Posterior vitreous detachment (PVD) and potential injection-related complications at week 4 were the primary outcome measures. Secondary outcomes included changes in best-corrected visual acuity (VA) (logMAR) and central macular thickness (CMT).
Results
Mean age of the patients was 54.35 years. Two patients had complete PVD and 3 patients had partial PVD. Four patients had decrease in CMT. The VA was not changed in 6 patients, improved in 1 patient, and decreased in 1 patient. No uveitis, endophthalmitis, or postinjection vitreous hemorrhage was observed.
Conclusions
This pilot study demonstrated the efficacy of urokinase-prepared IVAP injection on releasing vitreomacular traction and inducing vitreolysis.
TakanoAHirataAInomataYIntravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous. Am J Ophthalmol2005140654–60.
2.
GandorferAPutzEWelge-LüssenUGrüterichMUlbigMKampikAUltrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol2001856–10.
3.
AsamiTTerasakiHKachiSUltrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology2004111231–7.
4.
VerstraetenTCChapmanCHartzerMWinklerBSTreseMTWilliamsGAPharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol1993111849–54.
AzzoliniCD'AngeloAMaestranziGIntrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol2004138560–6.
7.
HirataATakanoAInomataYYonemuraNSagaraNTaniharaHPlasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: a pilot study. Retina2007271074–8.
8.
MargherioARMargherioRRHartzerMTreseMTWilliamsGAFerronePJPlasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology19981051617–20.
9.
WuWCDrenserKATreseMTWilliamsGACaponeAPediatric traumatic macular hole: results of autologous plasmin enzyme-assisted vitrectomy. Am J Ophthalmol2007144668–72.
10.
TreseMTWilliamsGAHartzerMKA new approach to stage 3 macular holes. Ophthalmology20001071607–11.
11.
Díaz-LlopisMUdaondoPCerveraE[Enzymatic vitrectomy by intravitreal autologous plasmin injection as initial treatment for macular epiretinal membranes and vitreomacular traction syndrome.]Arch Soc Esp Oftalmol20098491–100.
12.
TsukaharaYHondaSImaiHAutologous plasmin-assisted vitrectomy for stage 5 retinopathy of prematurity: a preliminary trial. Am J Ophthalmol2007144139–41.
13.
WuWCDrenserKALaiMCaponeATreseMTPlasmin enzyme-assisted vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity. Retina200828SupplS75–80.
14.
WilliamsJGTreseMTWilliamsGAHartzerMKAutologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology20011081902–5 discussion 1905-6.
15.
RizzoSPellegriniGBenocciFBeltingCBaicchiUVispiMAutologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery. Retina200626792–6.
AsamiTTerasakiHKachiSUltrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology2004111231–7.
20.
TreseMTWilliamsGAHartzerMKA new approach to stage 3 macular holes. Ophthalmology20001071607–11.
21.
SakumaTTanakaMInoueJMizotaASouriMIchinoseAUse of autologous plasmin during vitrectomy for diabetic maculopathy. Eur J Ophthalmol200616138–40.
22.
SakumaTTanakaMInoueMMizotaASouriMIchinoseAEfficacy of autologous plasmin for idiopathic macular hole surgery. Eur J Ophthalmol200515787–94.
23.
AzzoliniCD'AngeloAMaestranziGIntrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol2004138560–6.
24.
WilliamsJGTreseMTWilliamsGAHartzerMKAutologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology20011081902–5 discussion 1905-6.
25.
MargherioARMargherioRRHartzerMTreseMTWilliamsGAFerronePJPlasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology19981051617–20.
26.
TsukaharaYHondaSImaiHAutologous plasmin-assisted vitrectomy for stage 5 retinopathy of prematurity: a preliminary trial. Am J Ophthalmol2007144139–41.
27.
AlióJSánchezALudeñaSGarcíaSBergésJBatlleJVitreolisis enzimática: estudio experimental de un Nuevo método no mecánico de vitrectomia. Arch Soc Esp Oftalmol198753349–60.
JohnsonMWTractional cystoid macular edema: a subtle variant of the vitreomacular traction syndrome. Am J Ophthalmol2005140184–92.
31.
MelbergNSWilliamsDFBallesMWVitrectomy for vitreomacular traction syndrome with macular detachment. Retina199515192–7.
32.
PournarasCJKapetaniosADDonatiGVitrectomy for traction macular edema. Doc Ophthalmol199997439–47.
33.
McDonaldHRJohnsonRNSchatzHSurgical results in the vitreomacular traction syndrome. Ophthalmology19941011397–402 discussion 1403.
34.
GandorferAPutzEWelge-LüssenUGrüterichMUlbigMKampikAUltrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol2001856–10.
